- 商品介绍
- 规格参数
- 包装参数
General description
Cell-permeable and irreversible inhibitor of adenylate cyclase (IC50 = 250 µM).
Cell-permeable irreversible inhibitor of adenylate cyclase (IC50 = 250 µM).
Biochem/physiol Actions
Cell permeable: yes
Primary Target
Adenylate cyclase
Product does not compete with ATP.
Reversible: no
Target IC50: 250 µM against adenylate cyclase
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
Other Notes
Correia-de-Sa, P., and Ribeiro, J.A. 1994. Eur. J. Pharmacol. 271, 349.
Gorczynska, E., et al. 1994. Endocrinology134, 293.
Delpiano, M.A., and Acker, H. 1991. J. Neurochem.57, 291.
Lippe, C., and Ardizzone, C. 1991. Comp. Biochem. Physiol.99, 209.
Guellaen, G., et al. 1977. Biochim. Biophys. Acta 484, 465.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | solid |
| manufacturer/tradename | Calbiochem® |
| storage condition | OK to freeze,protect from light |
| color | white |
| solubility | DMSO: 10 mg/mL,water: 3 mg/mL,ethanol: 5 mg/mL |
| shipped in | ambient |
| storage temp. | 2-8°C |
| InChI | 1S/C23H36N2.ClH/c1-2-4-6-11-18-23(24-19-12-7-5-3-1)25-22-17-13-16-21(22)20-14-9-8-10-15-20;/h8-10,14-15,21-22H,1-7,11-13,16-19H2,(H,24,25);1H/t21-,22-;/m0./s1 |
| InChI key | CKOPQUCSDBVAQG-VROPFNGYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 1683.78
-
¥ 1563.36
-
询价
-
询价
-
¥ 1866.29
-
¥ 3109.49
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 2883.61
-
询价
-
询价
-
¥ 1564.00
-
¥ 3476.87
-
¥ 2288.54
-
询价
-
¥ 15537.49
-
¥ 25551.73
微信小程序
7X24小时在线咨询